Treatment of depression in adolescents with cognitive behavior therapy and medications: A commentary on the TADS project

Cognitive and Behavioral Practice

Volumn 12, Issue 2, 2005, Pages 149-155

  Hollon, Steven D ^a   Garber, Judy ^a   Shelton, Richard C ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; DEPRESSION; DRUG EFFICACY; HARM REDUCTION; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOTHERAPIST; REVIEW; SUICIDE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 32444450939     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(05)80019-7     Document Type: Note

References (31)

1. Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 88, 77-100.
2. Brent, D. A., Holder, D., Kolko, D., Birmaher, B., Baugher, M., Roth, C., lyengar, S., & Johnson, B. A. (1997). A clinical trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54, 877-885.
3. Brent, D. A., & Poling, K. (1997). Cognitive therafiy treatment manual for distressed and suicidal youth. Pittsburgh: Star Center (available from brentda@msx.upmc.edu).
4. Bridge, J. A., & Brent, D. A. (2004). Adolescents with depression (letter). JAMA, 292, 2578.
5. Clarke, G., Lewinsohn, P., & Hops, H. (1990). Instructor's manual for the adolescent coping with depression course (4th ed.). Eugene, OR: Castalia Press.
6. Clarke, G., Rohde, P., Lewinsohn, P. M., Hops, H., & Seeley, J. R. (1999). Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 272-279.
7. Cohen, D., Gerardin, P., Mazet, P., Purper-Ouakil, D., & Flament, M. F. (2004). Pharmacological treatment of adolescent major depression. Journal of Child and Adolescent Psychopharmacology, 14, 19-31.
8. Committee on Safety of Medicines. (2004). Selective serotonin reuptake inhibitor (SSRI) antidepressants: findings of the Committee on Safety of Medicine Working Group. Retrieved March 10, 2005, from http:// medicines.mhra.gov.uk/aboutagency/regframework/csm/csmhome. htm.
9. Courtet, P., Picot, M. C., Bellivier, F., Torres, S., Jollant, F., Michelon, C, Castelnau, D., Astruc, B., Buresi, C., & Malafosse, A. (2004). Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biological Psychiatry, 55, 46-51.
10. Curry, J. F. (2001). Specific psychotherapies for childhood and adolescent depression. Biological Psychiatry, 49, 1091-1100.
11. DeRubeis, R. J., & Feeley, M. (1990). Determinants of change in cognitive therapy for depression. Cognitive Therapy & Research, 14, 469-482.
12. DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O'Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., & Gallop, R. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, 409-416.
13. Elkin, I., Gibbons, R. D., Shea, M. T., & Shaw, B. F. (1996). Science is not a trial (but it can sometimes be a tribulation). Journal of Consulting and Clinical Psychology, 64, 92-103.
14. Feeley, M., DeRubeis, R.J., & Gelfand, L. A. (1999). The temporal relation of adherence and alliance to symptom change in cognitive therapy for depression. Journal of Consulting & Clinical Psychology, 67, 578-582.
15. Guy, W. (1976). ECDEU assessment manual for psychopharmacology (2nd ed). Washington, DC: US Government Printing Office, DHEW publication 76-388.
16. Holion, S. D., DeRubeis, R. J., Evans, M. D., Wiemer, M. J., Garvey, M. J., Grove, W. M., Se Tuason, V. B. (1992). Cognitive therapy, pharmacotherapy and combined cognitive-pharmacotherapy in the treatment of depression. Archives of General Psychiatry, 49, 774-781.
17. Hollon, S. D., & Shelton, R. C. (2001). Treatment guidelines for major depressive disorder. Behavior Therapy, 32, 235-258.
18. Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002). Treatment and prevention of depression. Psychological Science in the Public Interest, 3, 39-77.
19. Jacobson, N. S., & Hollon, S. D. (1990). Prospects for future comparisons between drugs and psychotherapy: Lessons from the CBT-versus-pharmacothcrapy exchange. Journal of Consulting and Clinical Psychology, 64, 104-108.
20. Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001). Behavioral activation treatment for depression: Returning to contextual roots. Clinical Psychology: Science find Practice., 8, 255-270.
21. Lewinsohn, P. M., & Clarke, G. N. (1999). Psychosocial treatments for adolescent depression. Clinical Psychology Review, 19, 329-842.
22. Reinecke, M. A., Ryan, N. E., & DuBois, D. L. (1998). Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 26-34.
23. Reynolds, W. M. (1987). Professional Manual for the Reynolds Adolescent Depression Scale. Odessa, FL.: Psychological Assessment Resources, Inc.
24. Rush, A. J., Fava, M., Wisniewski, S. R., Lavori P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Niereuberg, A. A., Quitkin, F. M., Kashuer, T. M., Kupfer, D. J., Rosenbaum, J. F., Alpert, J., Stewart, J. W., McGrath, P. J., Biggs, M. M., Shores-Wilson, K., Lebowitz, B. D., Ritz, L., Niederehe, G., & the STAR*D Investigators Group. (2004). Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25, 119-142.
25. Shaw, B. F., Elkin, I., Yamaguchi, J., Olmsted, M., Vallis, T. M., Dobson, K. S., Lowery, A., Sotsky, S. M., Watkins, J. T., & Imber, S. D. (1999). Therapist competence ratings in relation to clinical outcome in cognitive therapy of depression. Journal of Consulting and Clinical Psychology; 67, 837-846.
26. Smith, B., & Sechrest, L. (1991). Treatment of aptitude × treatment interactions. Journal of Consulting and Clinical Psychology, 59, 233-244.
27. Treatment for Adolescents with Depression Study (TADS) Team. (2003). Treatment for Adolescents With Depression Study (TADS): Rationale, design, and methods. Journal of the Academy of Child and Adolescent Psychiatry, 42, 531-542.
28. Treatment for Adolescents with Depression Study (TADS) Team. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treaimeni for Adolescents With Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807-820.
29. U.S. Food and Drug Administration Web Site. (2004). Worsening depression and suicidality in patients being treated with antidepressant medications. Available at: http://www.fda.gov/cder/ drug/antidepressants/AntidepressantsPHA. htm. Accessibility verified July 21, 2004.
30. Veiling, O. N., Setzer, N. J., & Albano, A. M. (2004). Update on and advances in assessment and cognitive-behavioral treatment of anxiety disorders in children and adolescents. Professional Psychology: Research and Practice, 35, 42-54.
31. Westen, D., Novotny, C. M., & Thompson-Brenner, H. (2004). The empirical status of empirically supported psychotherapies: Assumptions, findings, and reporting in controlled trials. Psychological Bulletin, 130, 631-663.